AMSBIO launches GMP-grade StemFit for Differentiation
Defined stem cell media offers easy transition to clinical manufacturing
Defined stem cell media offers easy transition to clinical manufacturing
BioPORTER protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.
AMSBIO launches new Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line
AMSBIO has added an extensive new resource to its website
AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively
AMSBIO reagents drive progress in Parkinson's, hypersomnia, and eco-friendly microbial research
CELLBANKER® integrates into cell manufacturing processes with personalized formulations, volumes, and packaging
The custom monoclonal antibody reveals potential HER2+ breast cancer target
The new kit is designed to allow researchers to easily and consistently generate muscle from human pluripotent stem cells
AMSBIO announces the release of the MagSi-DNA FFPE kit which can be used for manual and automated isolation of gDNA from mammalian FFPE tissue or cell samples
Access a wide range of cells that retain their original morphological and functional characteristics
AMSBIO has published an informative handbook for scientists who need to preserve or archive organoids in a research lab
Develop an optimized, custom cell line to stably express your gene of interest with AMSBIO
AMSBIO offers a wide range of small molecules to provide scientists with targeted tools to direct cell fates, making them crucial in areas including regenerative medicine and cancer research
New range of Vesicular Stomatitis Virus vectors offer a robust model of viral infection for cell engineering applications
AMSBIO offers a range of exosomes from a variety of biological sources, including cell culture supernatant, human plasma, serum, and urine
Stanford University researchers reproducibly grew clinical-grade iPSC’s in search of a new treatment for rare genetic disease